OGN has the ability to reduce proliferation and invasion of colorectal cancer cells by binding EGFR and promoting its internalization, resulting in the impairment of pro-mitotic signaling and EMT driven by the EGFR/AKT/Zeb-1 axis [64]. The gene discussed is EGFR; the disease is colorectal cancer.